<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ru">
	<id>https://amwiki.ru/index.php?action=history&amp;feed=atom&amp;title=%D0%9F%D1%80%D0%BE%D1%82%D0%B8%D0%B2%D0%BE%D0%BF%D0%B0%D1%80%D0%BA%D0%B8%D0%BD%D1%81%D0%BE%D0%BD%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B5_%D0%BF%D1%80%D0%B5%D0%BF%D0%B0%D1%80%D0%B0%D1%82%D1%8B</id>
	<title>Противопаркинсонические препараты - История изменений</title>
	<link rel="self" type="application/atom+xml" href="https://amwiki.ru/index.php?action=history&amp;feed=atom&amp;title=%D0%9F%D1%80%D0%BE%D1%82%D0%B8%D0%B2%D0%BE%D0%BF%D0%B0%D1%80%D0%BA%D0%B8%D0%BD%D1%81%D0%BE%D0%BD%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B5_%D0%BF%D1%80%D0%B5%D0%BF%D0%B0%D1%80%D0%B0%D1%82%D1%8B"/>
	<link rel="alternate" type="text/html" href="https://amwiki.ru/index.php?title=%D0%9F%D1%80%D0%BE%D1%82%D0%B8%D0%B2%D0%BE%D0%BF%D0%B0%D1%80%D0%BA%D0%B8%D0%BD%D1%81%D0%BE%D0%BD%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B5_%D0%BF%D1%80%D0%B5%D0%BF%D0%B0%D1%80%D0%B0%D1%82%D1%8B&amp;action=history"/>
	<updated>2026-04-24T18:16:42Z</updated>
	<subtitle>История изменений этой страницы в вики</subtitle>
	<generator>MediaWiki 1.40.1</generator>
	<entry>
		<id>https://amwiki.ru/index.php?title=%D0%9F%D1%80%D0%BE%D1%82%D0%B8%D0%B2%D0%BE%D0%BF%D0%B0%D1%80%D0%BA%D0%B8%D0%BD%D1%81%D0%BE%D0%BD%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B5_%D0%BF%D1%80%D0%B5%D0%BF%D0%B0%D1%80%D0%B0%D1%82%D1%8B&amp;diff=29693&amp;oldid=prev</id>
		<title>Aqui: /* N04B Дофаминергические средства */</title>
		<link rel="alternate" type="text/html" href="https://amwiki.ru/index.php?title=%D0%9F%D1%80%D0%BE%D1%82%D0%B8%D0%B2%D0%BE%D0%BF%D0%B0%D1%80%D0%BA%D0%B8%D0%BD%D1%81%D0%BE%D0%BD%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B5_%D0%BF%D1%80%D0%B5%D0%BF%D0%B0%D1%80%D0%B0%D1%82%D1%8B&amp;diff=29693&amp;oldid=prev"/>
		<updated>2020-03-23T23:30:32Z</updated>

		<summary type="html">&lt;p&gt;&lt;span dir=&quot;auto&quot;&gt;&lt;span class=&quot;autocomment&quot;&gt;N04B Дофаминергические средства&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;ru&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Предыдущая версия&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Версия от 02:30, 24 марта 2020&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l31&quot;&gt;Строка 31:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Строка 31:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** '''N04BX01''' [http://www.rlsnet.ru/mnn_index_id_2494.htm Толкапон]&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** '''N04BX01''' [http://www.rlsnet.ru/mnn_index_id_2494.htm Толкапон]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;== Примечания ==&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;{{примечания}}&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Категория:0Э]]&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Категория:0Э]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Категория:Ревизия &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;2019&lt;/del&gt;.&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;05&lt;/del&gt;.&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;14&lt;/del&gt;]]&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Категория:Ревизия &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;2020&lt;/ins&gt;.&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;03&lt;/ins&gt;.&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;24&lt;/ins&gt;]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Aqui</name></author>
	</entry>
	<entry>
		<id>https://amwiki.ru/index.php?title=%D0%9F%D1%80%D0%BE%D1%82%D0%B8%D0%B2%D0%BE%D0%BF%D0%B0%D1%80%D0%BA%D0%B8%D0%BD%D1%81%D0%BE%D0%BD%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B5_%D0%BF%D1%80%D0%B5%D0%BF%D0%B0%D1%80%D0%B0%D1%82%D1%8B&amp;diff=25955&amp;oldid=prev</id>
		<title>Aqui: /* N04B Дофаминергические средства */</title>
		<link rel="alternate" type="text/html" href="https://amwiki.ru/index.php?title=%D0%9F%D1%80%D0%BE%D1%82%D0%B8%D0%B2%D0%BE%D0%BF%D0%B0%D1%80%D0%BA%D0%B8%D0%BD%D1%81%D0%BE%D0%BD%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B5_%D0%BF%D1%80%D0%B5%D0%BF%D0%B0%D1%80%D0%B0%D1%82%D1%8B&amp;diff=25955&amp;oldid=prev"/>
		<updated>2019-05-14T03:38:38Z</updated>

		<summary type="html">&lt;p&gt;&lt;span dir=&quot;auto&quot;&gt;&lt;span class=&quot;autocomment&quot;&gt;N04B Дофаминергические средства&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;ru&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Предыдущая версия&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Версия от 06:38, 14 мая 2019&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l32&quot;&gt;Строка 32:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Строка 32:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Категория:0Э]]&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Категория:0Э]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;[[Категория:Ревизия 2019.05.14]]&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Aqui</name></author>
	</entry>
	<entry>
		<id>https://amwiki.ru/index.php?title=%D0%9F%D1%80%D0%BE%D1%82%D0%B8%D0%B2%D0%BE%D0%BF%D0%B0%D1%80%D0%BA%D0%B8%D0%BD%D1%81%D0%BE%D0%BD%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B5_%D0%BF%D1%80%D0%B5%D0%BF%D0%B0%D1%80%D0%B0%D1%82%D1%8B&amp;diff=21772&amp;oldid=prev</id>
		<title>Aqui в 01:22, 17 июня 2018</title>
		<link rel="alternate" type="text/html" href="https://amwiki.ru/index.php?title=%D0%9F%D1%80%D0%BE%D1%82%D0%B8%D0%B2%D0%BE%D0%BF%D0%B0%D1%80%D0%BA%D0%B8%D0%BD%D1%81%D0%BE%D0%BD%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B5_%D0%BF%D1%80%D0%B5%D0%BF%D0%B0%D1%80%D0%B0%D1%82%D1%8B&amp;diff=21772&amp;oldid=prev"/>
		<updated>2018-06-17T01:22:33Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Новая страница&lt;/b&gt;&lt;/p&gt;&lt;div&gt;'''Противопаркинсонические препараты''' — рубрика N04 [[АТХ|Анатомо-терапевтическо-химической классификации лекарственных средств]].&lt;br /&gt;
&lt;br /&gt;
Содержание рубрики:&lt;br /&gt;
&lt;br /&gt;
== '''N04A''' Антихолинергические средства ==&lt;br /&gt;
&lt;br /&gt;
* '''N04AA''' Третичные амины&lt;br /&gt;
** '''N04AA01''' [[Тригексифенидил]]&lt;br /&gt;
** '''N04AA02''' [[Бипериден]]&lt;br /&gt;
* '''N04AC''' Тропиновые эфиры или производные тропина&lt;br /&gt;
** [http://www.rlsnet.ru/mnn_index_id_1301.htm Дифенилтропин]&lt;br /&gt;
&lt;br /&gt;
== '''N04B''' Дофаминергические средства ==&lt;br /&gt;
&lt;br /&gt;
* '''N04BA''' Допа и ее производные&lt;br /&gt;
** '''N04BA01''' [http://www.rlsnet.ru/mnn_index_id_3351.htm Леводопа + Бенсеразид]&lt;br /&gt;
** '''N04BA02''' [http://www.rlsnet.ru/mnn_index_id_3349.htm Леводопа + Карбидопа]&lt;br /&gt;
** '''N04BA03''' [http://www.rlsnet.ru/mnn_index_id_5305.htm Леводопа, ингибитор декарбоксилазы и ингибитор КОМТ]&lt;br /&gt;
* '''N04BB '''Производные адамантана&lt;br /&gt;
** '''N04BB01''' [http://www.rlsnet.ru/mnn_index_id_289.htm Амантадин]&lt;br /&gt;
* '''N04BC''' Агонисты дофаминовых рецепторов&lt;br /&gt;
** '''N04BC01''' [http://www.rlsnet.ru/mnn_index_id_491.htm Бромокриптин]&lt;br /&gt;
** '''N04BC04''' [http://www.rlsnet.ru/mnn_index_id_5545.htm Ропинирол]&lt;br /&gt;
** '''N04BC05''' [http://www.rlsnet.ru/mnn_index_id_2671.htm Прамипексол]&lt;br /&gt;
** '''N04BC08''' [http://www.rlsnet.ru/mnn_index_id_2756.htm Пирибедил]&lt;br /&gt;
** '''N04BC09''' [http://www.rlsnet.ru/mnn_index_id_6122.htm Ротиготин]&lt;br /&gt;
* '''N04BD''' Ингибиторы моноаминоксидазы типа B&lt;br /&gt;
** '''N04BD01''' [http://www.rlsnet.ru/mnn_index_id_1430.htm Селегилин]&lt;br /&gt;
** '''N04BD02''' [http://www.rlsnet.ru/mnn_index_id_3836.htm Разагилин]&lt;br /&gt;
* '''N04BX''' Прочие дофаминергические препараты&lt;br /&gt;
** '''N04BX01''' [http://www.rlsnet.ru/mnn_index_id_2494.htm Толкапон]&lt;br /&gt;
&lt;br /&gt;
[[Категория:0Э]]&lt;/div&gt;</summary>
		<author><name>Aqui</name></author>
	</entry>
	<entry>
		<id>https://amwiki.ru/index.php?title=%D0%9F%D1%80%D0%BE%D1%82%D0%B8%D0%B2%D0%BE%D0%BF%D0%B0%D1%80%D0%BA%D0%B8%D0%BD%D1%81%D0%BE%D0%BD%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B5_%D0%BF%D1%80%D0%B5%D0%BF%D0%B0%D1%80%D0%B0%D1%82%D1%8B&amp;diff=8589&amp;oldid=prev</id>
		<title>94.231.146.37 в 17:39, 19 мая 2013</title>
		<link rel="alternate" type="text/html" href="https://amwiki.ru/index.php?title=%D0%9F%D1%80%D0%BE%D1%82%D0%B8%D0%B2%D0%BE%D0%BF%D0%B0%D1%80%D0%BA%D0%B8%D0%BD%D1%81%D0%BE%D0%BD%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B5_%D0%BF%D1%80%D0%B5%D0%BF%D0%B0%D1%80%D0%B0%D1%82%D1%8B&amp;diff=8589&amp;oldid=prev"/>
		<updated>2013-05-19T17:39:39Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Новая страница&lt;/b&gt;&lt;/p&gt;&lt;div&gt;'''Противопаркинсонические препараты''' — рубрика N04 [[АТХ|Анатомо-терапевтическо-химической классификации лекарственных средств]].&lt;br /&gt;
&lt;br /&gt;
Содержание рубрики:&lt;br /&gt;
* '''N04A''' Антихолинергические средства&lt;br /&gt;
** '''N04AA''' Третичные амины&lt;br /&gt;
*** [http://www.rlsnet.ru/atc_index_id_1223.htm '''N04AA01''' Тригексифенидил]&lt;br /&gt;
*** [http://www.rlsnet.ru/atc_index_id_1224.htm '''N04AA02''' Бипериден]&lt;br /&gt;
** '''N04AC''' Тропиновые эфиры или производные тропина&lt;br /&gt;
*** [http://www.rlsnet.ru/mnn_index_id_1301.htm Дифенилтропин]&lt;br /&gt;
* [http://www.rlsnet.ru/atc_index_id_1225.htm '''N04B''' Дофаминергические средства]&lt;br /&gt;
** [http://www.rlsnet.ru/atc_index_id_1226.htm '''N04BA''' Допа и ее производные]&lt;br /&gt;
*** [http://www.rlsnet.ru/atc_index_id_1226_sort_mnn.htm '''N04BA01''' Леводопа + Бенсеразид]&lt;br /&gt;
*** ~&lt;br /&gt;
** '''N04BB01''' Амантадин&lt;br /&gt;
*** [http://www.rlsnet.ru/mnn_index_id_289.htm Амантадин]&lt;br /&gt;
** [http://www.rlsnet.ru/atc_index_id_1231.htm '''N04BC''' Агонисты дофаминовых рецепторов]&lt;br /&gt;
*** ~&lt;br /&gt;
** [http://www.rlsnet.ru/atc_index_id_1235.htm '''N04BD''' Ингибиторы моноаминоксидазы типа B]&lt;br /&gt;
*** ~&lt;br /&gt;
** '''N04BX''' Прочие дофаминергические препараты&lt;br /&gt;
*** '''N04BX01''' Толкапон&lt;br /&gt;
**** [http://www.rlsnet.ru/mnn_index_id_2494.htm Толкапон] ,&lt;/div&gt;</summary>
		<author><name>94.231.146.37</name></author>
	</entry>
</feed>